Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 3/5 criteria met. Data as of 03/10/2026.
- ✅ Price trend passed
- ✅ Growth passed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2018 → 2019: 31.30%
Price change 2019 → 2020: 23.95%
Price change 2020 → 2021: 58.19%
Price change 2021 → 2022: -12.36%
Price change 2022 → 2023: -5.23%
Price change 2023 → 2024: 32.97%
Price change 2024 → 2025: 25.64%
Price change 2025 → 2026: -5.62%
Price change 2026 (year to date): -5.16%
Financial growth
Revenue CAGR (8 years): 9.78%
Earnings CAGR (8 years): 21.49%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.81
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 24.75
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 7.84% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Nasdaq, Inc. | 28.1 | 0.81 | +6.5 % | 🔒 |
| Société Générale S.A. | 7.8 | 2.38 | +2.3 % | – |
| Amundi S.A. | 13.1 | 0.16 | +8.4 % | ★ 5/5 |
| Allianz SE | 14.0 | 0.46 | +2.6 % | ★ 4/5 |
| Edenred S.A. | 12.2 | – | +7.2 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|